Q1 FY27 Revenue Growth 10-14%
Management guided Q1 FY27 revenue growth of 10-14% YoY, driven by volume and price, with FX tailwind of 7-9%.
UPL / guidance tracker
Keep management guidance in view.
UPL · forward-looking guidance across the available source record.
Research layer active
Guidance tracker
What management said would happen.
revenue
Q1 FY27 EBITDA Growth 14-18%
EBITDA growth guided at 14-18% for Q1 FY27, reflecting operating leverage despite seasonally low quarter.
Capex Guidance $300-350M for FY27
Capex expected to increase to $300-350 million from $261 million in FY26, focused on specialty chemicals and backward integration.
Net Debt/EBITDA Target 1.2-1.5x Medium Term
Target leverage ratio of 1.2-1.5x in the medium term, with current at 1.6x; will maintain optimal capital structure.